Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (7814)	11/24/1998 6:32:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

Get a grip? When a company tells you publicly that they anticipate approval of Neuprex? Suppose George, you and your new ally show me where any other ethical Biotech proposes a move of domicile to Bermuda for the express purpose of anticipating approval of a product. Me get a grip, how about Xoma getting a grip if Neuprex is not approved? One more time, read the press release and try to see how uncommon it is, especially for Xoma. One thing is for sure, know what a gamble this stock is if Neuprex does not get approval especially after the wording of the press release. Only my opinions.